
WHF Position Statement on COVID Vaccination
References
- World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard.
https://covid19.who.int . - V’Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: Implications for SARS-CoV-2. Nat Rev Microbiol. 2021; 19: 155–170. DOI: 10.1038/s41579-020-00468-6
- Wang N, Shang J, Jiang S, Du L. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses. Front Microbiol. 2020; 11: 298. DOI: 10.3389/fmicb.2020.00298
- Mohan T, Verma P, Rao DN. Novel adjuvants & delivery vehicles for vaccines development: A road ahead. Indian J Med Res. 2013; 138: 779–795.
- Forni G, Mantovani A, Covid-19 Commission of Accademia Nazionale dei Lincei R. COVID-19 vaccines: Where we stand and challenges ahead. Cell Death Differ. 2021. DOI: 10.1038/s41418-020-00720-9
- Times. TNY. Covid-19 Vaccine Tracker Updates: The Latest nytimescom 2021; Sect.
nytimes.com . https://wwwlinceiit/sites/default/files/documenti/Commissioni/ANL_Comm_Covid-19_Vaccines_1november2020pdf .- Liu MA. Immunologic basis of vaccine vectors. Immunity. 2010; 33: 504–515. DOI: 10.1016/j.immuni.2010.10.004
- CDC Report. Emerging SARS-CoV-2 Variants
https://wwwcdcgov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variantshtml . - Tang JW, Toovey OTR, Harvey KN, Hui DDS. Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK. J Infect. 2021. DOI: 10.1016/j.jinf.2021.01.007
- Iwata-Yoshikawa N, Uda A, Suzuki T, et al. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine. J Virol. 2014; 88: 8597–8614. DOI: 10.1128/JVI.00983-14
- Baden LR, El Sahly HM, Essink B, et al.Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. The New England journal of medicine. 2021; 384: 403–416. DOI: 10.1056/NEJMoa2035389
- Walsh EE, Frenck RW,
Jr. , Falsey AR, et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. The New England journal of medicine. 2020; 383: 2439–2450. DOI: 10.1056/NEJMoa2027906 - Perricone C, Triggianese P, Bartoloni E, et al.The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmun. 2020; 111: 102468. DOI: 10.1016/j.jaut.2020.102468
- Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020; 141: 1648–1655. DOI: 10.1161/CIRCULATIONAHA.120.046941
- Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. Journal of the American College of Cardiology. 2020; 75: 2352–2371. DOI: 10.1016/j.jacc.2020.03.031
- Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA cardiology. 2020; 5: 831–840. DOI: 10.1001/jamacardio.2020.1286
- Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA internal medicine. 2020; 180: 934–943. DOI: 10.1001/jamainternmed.2020.0994
- Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England journal of medicine. 2020; 382: 1199–1207. DOI: 10.1056/NEJMoa2001316
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395: 1054–1062. DOI: 10.1016/S0140-6736(20)30566-3
- Roth GA, Johnson C, Abajobir A, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. Journal of the American College of Cardiology. 2017; 70: 1–25. DOI: 10.1016/j.jacc.2017.04.052
- Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020; 7: 11. DOI: 10.1186/s40779-020-00240-0
- Bohm M, Frey N, Giannitsis E, Sliwa K, Zeiher AM. Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: Expert document from the German Cardiac Society and the World Heart Federation. Clinical research in cardiology: Official journal of the German Cardiac Society. 2020; 109: 1446–1459. DOI: 10.1007/s00392-020-01656-3
- Haga S, Yamamoto N, Nakai-Murakami C, et al. Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry. Proc Natl Acad Sci U S A. 2008; 105: 7809–7814. DOI: 10.1073/pnas.0711241105
- Grover SP, Mackman N. Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis. Arterioscler Thromb Vasc Biol. 2018; 38: 709–725. DOI: 10.1161/ATVBAHA.117.309846
- Glowacka I, Bertram S, Herzog P, et al. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol. 2010; 84: 1198–1205. DOI: 10.1128/JVI.01248-09
- Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res. 2020; 126: 1456–1474. DOI: 10.1161/CIRCRESAHA.120.317015
- Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. The Lancet. Respiratory medicine. 2020; 8: 475–481. DOI: 10.1016/S2213-2600(20)30079-5
- Zeng JH, Liu YX, Yuan J, et al. First case of COVID-19 complicated with fulminant myocarditis: A case report and insights. Infection. 2020; 48: 773–777. DOI: 10.1007/s15010-020-01424-5
- Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: From pathophysiology to clinical management. Nat Rev Endocrinol. 2021; 17: 11–30. DOI: 10.1038/s41574-020-00435-4
- Radder RS, Quinn AE, Georges A, Sarre SD, Shine R. Genetic evidence for co-occurrence of chromosomal and thermal sex-determining systems in a lizard. Biol Lett. 2008; 4: 176–178. DOI: 10.1098/rsbl.2007.0583
- Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. The New England journal of medicine. 2013; 368: 2004–2013. DOI: 10.1056/NEJMra1216063
- Chakafana G, Mutithu D, Hoevelmann J, Ntusi N, Sliwa K. Interplay of COVID-19 and cardiovascular diseases in Africa: An observational snapshot. Clinical research in cardiology: Official journal of the German Cardiac Society. 2020; 109: 1460–1468. DOI: 10.1007/s00392-020-01720-y
- Magadum A, Kishore R. Cardiovascular Manifestations of COVID-19 Infection. Cells. 2020; 9; 2508. DOI: 10.3390/cells9112508
- Armstrong SM, Wang C, Tigdi J, et al. Influenza infects lung microvascular endothelium leading to microvascular leak: Role of apoptosis and claudin-5. PloS one. 2012; 7: e47323. DOI: 10.1371/journal.pone.0047323
- Pothineni NVK, Subramany S, Kuriakose K, et al. Infections, atherosclerosis, and coronary heart disease. European heart journal. 2017; 38: 3195–3201. DOI: 10.1093/eurheartj/ehx362
- Grossman E. Does increased oxidative stress cause hypertension? Diabetes Care. 2008; 31(Suppl 2): S185–189. DOI: 10.2337/dc08-s246
- World Health Organization. Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca.
https://wwwwhoint/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222–20211 . - COVAX Explained.
https://wwwgaviorg/vaccineswork/covax-explained - Mallapaty S. Vaccines are curbing COVID: Data from Israel show drop in infections. Nature. 2021; 590: 197. DOI: 10.1038/d41586-021-00316-4.
- Petter E, Mor O, Zuckerman N, et al. Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2. 2021.
https://githubcom/ellapetter/COVID19/blob/main/Initial%20real%20world%20evidence%20for%20lower%20transmissibility%20of%20individuals%20who%20have%20been%20vaccinated%20by%20BNT162b2pdf . https://www.change.org/p/sa-department-of-health-we-need-a-vaccine-plan-now?recruiter=24520734&utm_source=share_petition&utm_medium=email&utm_campaign=share_email_responsive&recruited_by_id=e0e0a55d-b531-4ede-9d6d-67ff8cdc0a66 ;https://petition.parliament.uk/petitions/562854 .- CDC Covid Data Tracker. 2021.
https://covid.cdc.gov/covid-data-tracker/#health-care-personnel . - Rampini SK, Wolfensberger A, Sax H, Thienemann F. Preventing intrahospital transmission of COVID-19: Experience from the University Hospital Zurich in Switzerland. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2020; 110: 709–710.
DOI: https://doi.org/10.5334/gh.1027 | Journal eISSN: 2211-8179
Language: English
Submitted on: Mar 8, 2021
Accepted on: Mar 29, 2021
Published on: Apr 27, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2021 F. Thienemann, G. Chakafana, D. Piñeiro, F. J. Pinto, P. Perel, K. Singh, J.-L. Eiselé, D. Prabhakaran, K. Sliwa, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.